Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
Clinical trial NCT03040726 · COMPLETED
Trial details
- NCT number
- NCT03040726
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-03
- Primary completion
- 2022-02-14
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.